Pyrimethamine suppresses STAT3 action in metastatic breast cancer cell lines ex-vivo by reducing tumor growth and invasion and by increasing Lamp1 production in tumour-infiltrating CD8+T lymphocytes [98]. The gene discussed is CD8A; the disease is neoplasm.